Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Priming theta burst stimulation intensity for improving arm recovery after stroke

Official title: Optimizing the Intensity of Priming Theta Burst Stimulation to Improve Hemiparetic Upper Limb Motor Functions After Stroke: a Randomized Controlled Trial

Run by The Hong Kong Polytechnic University · NCT06509789 · Data updated 2026-11-12

This trial will test whether low‑intensity priming intermittent theta burst stimulation helps people with chronic stroke regain better arm movement compared with conventional priming, nonpriming, or sham stimulation.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment100 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong, Hong Kong)
StatusRecruiting
StartedJuly 2, 2025
Main results expectedDecember 31, 2026
Study endsSeptember 30, 2027
Registry record updatedAugust 24, 2026
Trial IDNCT06509789 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with unilateral upper‑limb motor dysfunction from ischemic stroke at least 6 months prior, residual function at FTHUE levels 2–6, able to undergo MRI and TMS, and able to provide informed consent are ideal candidates.

Probably not a fit

Patients with contraindications to TMS or MRI, recent (<6 months) or bilateral strokes, major comorbid neurological disease, or those with very minimal or no residual arm movement are unlikely to receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will enroll 108 adults with chronic unilateral ischemic stroke and moderate-to-severe upper‑limb impairment. Participants are randomly assigned to one of four groups (low‑intensity priming iTBS, conventional‑intensity priming iTBS, nonpriming iTBS, or double‑sham) and receive three stimulation sessions per week for four weeks followed by 60 minutes of standardized motor training each session. Outcomes include clinical upper‑limb motor tests and measures of cortical excitation/inhibition using TMS and EEG, with MRI used to confirm lesion location. The study compares a 55% RMT priming protocol plus 70% RMT iTBS against other priming intensities and sham to see which produces the best motor and neurophysiologic changes.

Why it matters

Potential benefit: If successful, the approach could offer a more effective noninvasive stimulation protocol to speed and enhance recovery of arm movement after chronic stroke.

How similar studies have gone: Previous small studies of iTBS and priming paradigms have shown mixed but promising effects on cortical excitability and motor recovery, while low‑intensity priming specifically remains relatively novel and less tested in large randomized trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. Unilateral upper limb motor dysfunction caused by ischemic or hemorrhagic stroke, with stroke onset≥6 months. Diagnosis will be verified using discharge summary and radiological reports issued by Hospital Authority. Qualifying participants will undergo structural magnetic resonance imaging (MRI) at the University Research Facility in Behavioral and Systems Neuroscience (UBSN) at PolyU to further confirm their lesion location in the period of experimental participation.
2. Age between 18 and 80 years.
3. Residual upper limb functions between levels 2-7 in the FTHUE, indicating moderately-to-severely impaired upper limb motor functions.
4. Capable of providing informed written consent. Exclusion Criteria

Patients who meet any of the following criteria will be excluded:

1. any contraindications to TMS (screened by the safety checklist by Rossi(33)) and/or MRI (screened by the MRI safety checklist offered by UBSN \[see supplement\]).
2. Diagnosed with any concomitant neurological disease other than stroke.
3. signs of cognitive impairment, with a Montreal cognitive assessment score\<21/22 out of 30 (34).
4. Severe spasticity in the hemiparetic upper limb muscles, with a Modified Ashworth score \> 2 (35).

Where it's running

  • Jack Jiaqi Zhang
    Hong Kong, Hong Kong, Hong Kong
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.